Abbott (NYSE: ABT) announced today that the FDA approved its Volt pulsed field ablation (PFA) system to treat patients with AFib.

This content is sponsored by MedStar Washington Hospital Center. Atrial fibrillation, or AFib, is the most common type of irregular heartbeat with at least 2.7 million Americans affected, according to ...

If you sometimes experience a racing or irregular heartbeat, it may be caused by atrial fibrillation (AFib), the most common type of heart arrhythmia. AFib can make you five times more likely to have ...

The FDA approved Abbott's Volt PFA System for atrial fibrillation, supported by VOLT-AF trial data showing strong safety and ...

Convergent hybrid ablation is an innovative treatment for a type of irregular heart rhythm called atrial fibrillation (AFib). The treatment is a two-stage procedure that combines the expertise of our ...

If you sometimes experience a racing or irregular heartbeat, it may be caused by atrial fibrillation (AFib), the most common type of heart arrhythmia. AFib can make you five times more likely to have ...

Atrial fibrillation is one of the most common heart arrhythmias that people experience, affecting up to six million people in the U.S. each year. It happens when the heart beats irregularly, meaning ...

WAY IN A BRAND NEW HEART PROCEDURE. IT’S DESIGNED TO HELP AFIB OR ATRIAL FIBRILLATION. IT WAS JUST APPROVED BY THE FDA IN DECEMBER. AND THIS MONTH, AN OMAHA WOMAN WAS ONE OF THE FIRST TO GET IT DONE.

Over 5 million Americans have atrial fibrillation, or AFib, an arrhythmia heart disorder in which the heart’s upper chambers ...

Not everyone with atrial fibrillation needs to correct it. Some people with an irregular heartbeat can go years without any treatment other than stroke prevention. "A lot of people have so-called ...

Your risk of getting atrial fibrillation (AFib) goes up as you age. It’s also becoming more common. The CDC predicts over 12 million Americans will have it by the year 2030. AFib treatment can be ...